Search Results - "BELIMEZI, Maria"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Analysis of nAChR Autoantibodies Against Extracellular Epitopes in MG Patients by Michail, Maria, Zouvelou, Vasiliki, Belimezi, Maria, Haroniti, Anna, Zouridakis, Marios, Zisimopoulou, Paraskevi

    Published in Frontiers in neurology (28-03-2022)
    “…Myasthenia gravis (MG) is an autoimmune disorder caused by autoantibodies targeting components of the postsynaptic membrane of the neuromuscular junction…”
    Get full text
    Journal Article
  2. 2

    Age at sampling and sex distribution of AChRAb vs. MuSKAb myasthenia gravis in a large Greek population by Belimezi, Maria, Kalliaropoulos, Antonios, Jiménez, Juan, Garcia, Irene, Mentis, Alexios-Fotios A., Chrousos, George P.

    Published in Clinical neurology and neurosurgery (01-09-2021)
    “…Myasthenia gravis (MG) is a typical B-cell-mediated neuromuscular junction disease that can be classified into seropositive and seronegative subtypes…”
    Get full text
    Journal Article
  3. 3

    Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR by Pavlidou, Anastasia, Dalamaga, Maria, Kroupis, Christos, Konstantoudakis, George, Belimezi, Maria, Athanasas, George, Dimas, Kleanthi

    Published in World journal of gastroenterology : WJG (28-03-2011)
    “…AIM:To investigate three isoforms of survivin in colorectal adenocarcinomas.METHODS:We used the LightCycler Technology(Roche),along with a common forward…”
    Get full text
    Journal Article
  4. 4

    Growth inhibition of breast cancer cell lines overexpressing Her2/neu by a novel internalized fully human Fab antibody fragment by BELIMEZI, Maria M, PAPANASTASSIOU, Danai, MERKOURI, Efrossini, BAXEVANIS, Constantin N, MAMALAKI, Avgi

    Published in Cancer Immunology, Immunotherapy (01-09-2006)
    “…The Her2/neu oncogene is overexpressed in various human cancers of epithelial origin and is associated with increased metastatic potential and poor prognosis…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Characterization of the nicotinic acetylcholine receptor antibodies after an unexpected increase of antibody titer in thymoma associated myasthenia gravis patients by Zouvelou, Vasiliki, Michail, Maria, Belimezi, Maria, Haroniti, Anna, Zisimopoulou, Paraskevi

    Published in Neuromuscular disorders : NMD (01-10-2022)
    “…•Anti-nAChR autoAbs titer increased in sera of two TMG patients with stable symptoms.•The titer's increase correlated with an increase of non-anti-α1…”
    Get full text
    Journal Article
  7. 7

    Diagnostic significance of IgG and albumin indices versus oligoclonal band types in demyelinating disorders by Belimezi, Maria, Kalliaropoulos, Antonios, Mentis, Alexios-Fotios A, Chrousos, George P

    Published in Journal of clinical pathology (01-03-2023)
    “…The laboratory diagnosis of demyelinating inflammatory disorders (DIDs) relies on both intrathecal oligoclonal band (OCB) positivity and IgG index. Although…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis by Zhang, Bin, Tzartos, John S, Belimezi, Maria, Ragheb, Samia, Bealmear, Beverly, Lewis, Richard A, Xiong, Wen-Cheng, Lisak, Robert P, Tzartos, Socrates J, Mei, Lin

    Published in Archives of neurology (Chicago) (01-04-2012)
    “…To determine whether patients with myasthenia gravis (MG) have serum antibodies to lipoprotein-related protein 4 (LRP4), a newly identified receptor for agrin…”
    Get more information
    Journal Article
  10. 10

    Discovery of Potent Vascular Endothelial Growth Factor Receptor-2 Inhibitors by Papakyriakou, Athanasios, Katsarou, Maria E., Belimezi, Maria, Karpusas, Michael, Vourloumis, Dionisios

    Published in ChemMedChem (04-01-2010)
    “…Substantial evidence over the last decades has implicated uncontrolled angiogenesis with various pathological states, including cancer. Vascular endothelial…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15